Table 2.
Clinical impact in preprocedural sizing.
| Patient no. | CT (mm) | Freixa | Decision SoC | Confidence SoC | Decision FEops | Confidence FEops | Implanted |
|---|---|---|---|---|---|---|---|
| n = 7 (46.7%) | Similar decisions SoC and FEops correlating with implanted device | ||||||
| 1 | 16 × 17 | 22 | 20 | 8 | 20 | 9 | 20 |
| 2 | 17 × 22 | 25 | 22 | 7 | 22 | 9 | 22 |
| 8 | 13 × 19 | 20 | 20 | 8 | 20 | 8 | 20 |
| 10 | 27 × 37 | 34 | 34 | 4 | 34 | 7 | 34 |
| 11 | 19 × 37 | 34 | 31 | 6 | 31 | 8 | 31 |
| 13 | 21 × 36 | 34 | 34 | 6 | 34 | 8 | 34 |
| 14 | 19 × 22 | 25 | 25 | 6 | 25 | 8 | 25 |
| Average | 6.4 ± 1.4 | 8.1 ± 0.7 | p=0.003 | ||||
|
| |||||||
| n = 4 (26.7%) | Different decisions SoC and FEops. FEops correlated with implanted device | ||||||
| 3 | 16 × 18 | 22 | 20 | 8 | 22 | 8 | 22 |
| 5 | 19 × 25 | 28 | 25 | 7 | 22 | 7 | 22 |
| 6 | 14 × 21 | 22 | 22 | 7 | 20 | 7 | 20 |
| 7 | 19 × 26 | 28 | 28 | 7 | 25 | 7 | 25 |
| Average | 7.3 ± 0.5 | 7.3 ± 0.5 | p=NS | ||||
|
| |||||||
| n = 2 (13.3%) | Similar decisions SoC and FEops, not correlating with implanted device | ||||||
| 4 | 21 × 31 | 31 | 31 | 7 | 31 | 8 | 28 |
| 12 | 22 × 23 | 28 | 25 | 8 | 25 | 6 | 28 |
| Average | 7.5 | 7 | p=NS | ||||
|
| |||||||
| n = 1 (6.7%) | Different decisions SoC and FEops, none correlating with implanted device | ||||||
| 15 | 14 × 19 | 22 | 22 | 8 | 20 | 7 | 18 |
| n = 1 (6.7%) | Similar decisions SoC and FEops, but no implanted device | ||||||
| 9 | 22 × 31 | 31 | 31 | 7 | 31 | 7 | NA |
CT: computed tomography measurement of landing zone, NS: nonsignificant, SoC: standard of care, and Freixa: sizing based on the sizing table from Freixa et al. [6].